healthprotocol.wiki

medication-masitinib-generic

Outcomes

01
symptom-cumulative-response-rate-greater-than-75-percent-symptom-improvement
1 evidence row
- lortholary_2017_rct_masitinib-for-treatment-of-severely-symptomatic-indolent-systemic-mastocytosis